Hilton Worldwide (HLT) PT Raised to $178 at Argus

Argus analyst John Staszak raised the price target on Hilton Worldwide (NYSE: HLT) to $178.00 (from $162.00) while maintaining a Buy rating.

• We believe that the continued rollout of coronavirus vaccines will lead to increased room demand, along with higher RevPAR and management fees.
• We are maintaining our 2021 EPS estimate of $2.65 and raising our 2022 estimate to $4.32 from $4.29. Both estimates are above consensus.
• HLT shares appear attractively valued at 36-times our revised 2022 EPS estimate, below the average of 41 for industry peers.
• Our long-term rating on HLT remains BUY based on the company’s solid development pipeline, new brands, and well-regarded loyalty program.

You May Also Be Interested In

• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• Oppenheimer Reiterates Outperform Rating on NVIDIA (NVDA) Into EPS
• GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold